• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮癌干细胞逃避补体监测需要SOX2对CD59的调控。

CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance.

作者信息

Chen Jianfeng, Ding Peipei, Li Ling, Gu Hongyu, Zhang Xin, Zhang Long, Wang Na, Gan Lu, Wang Qi, Zhang Wei, Hu Weiguo

机构信息

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Collaborative Innovation Center of Cancer Medicine, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai 200032, China.

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Collaborative Innovation Center of Cancer Medicine, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai 200032, China; Department of Immunology, Shanghai Medical College, Fudan University, 130 Dong'an Road, Shanghai 200032, China.

出版信息

Stem Cell Reports. 2017 Jan 10;8(1):140-151. doi: 10.1016/j.stemcr.2016.11.008. Epub 2016 Dec 22.

DOI:10.1016/j.stemcr.2016.11.008
PMID:28017655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5233323/
Abstract

Cancer stem cells (CSCs) are highly associated with therapy resistance and metastasis. Interplay between CSCs and various immune components is required for tumor survival. However, the response of CSCs to complement surveillance remains unknown. Herein, using stem-like sphere-forming cells prepared from a mammary tumor and a lung adenocarcinoma cell line, we found that CD59 was upregulated to protect CSCs from complement-dependent cytotoxicity. CD59 silencing significantly enhanced complement destruction and completely suppressed tumorigenesis in CSC-xenografted nude mice. Furthermore, we identified that SOX2 upregulates CD59 in epithelial CSCs. In addition, we revealed that SOX2 regulates the transcription of mCd59b, leading to selective mCD59b abundance in murine testis spermatogonial stem cells. Therefore, we demonstrated that CD59 regulation by SOX2 is required for stem cell evasion of complement surveillance. This finding highlights the importance of complement surveillance in eliminating CSCs and may suggest CD59 as a potential target for cancer therapy.

摘要

癌症干细胞(CSCs)与治疗抗性和转移高度相关。肿瘤存活需要CSCs与各种免疫成分之间的相互作用。然而,CSCs对补体监测的反应仍然未知。在此,我们使用从乳腺肿瘤和肺腺癌细胞系制备的类干细胞球形成细胞,发现CD59上调以保护CSCs免受补体依赖性细胞毒性作用。CD59沉默显著增强补体破坏,并完全抑制CSC异种移植裸鼠中的肿瘤发生。此外,我们确定SOX2在上皮CSCs中上调CD59。此外,我们揭示SOX2调节mCd59b的转录,导致小鼠睾丸精原干细胞中选择性mCD59b丰度。因此,我们证明SOX2对CD59的调节是干细胞逃避补体监测所必需的。这一发现突出了补体监测在消除CSCs中的重要性,并可能提示CD59作为癌症治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/2a6e1f7fcf1a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/bde27f41418f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/a50da6a778c0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/4d57e01dd3ae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/f8b24cbac69b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/4c0f8615ba08/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/2a6e1f7fcf1a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/bde27f41418f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/a50da6a778c0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/4d57e01dd3ae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/f8b24cbac69b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/4c0f8615ba08/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b77/5233323/2a6e1f7fcf1a/gr6.jpg

相似文献

1
CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance.上皮癌干细胞逃避补体监测需要SOX2对CD59的调控。
Stem Cell Reports. 2017 Jan 10;8(1):140-151. doi: 10.1016/j.stemcr.2016.11.008. Epub 2016 Dec 22.
2
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.转化生长因子-β诱导上皮-间质转化对补体依赖性细胞毒性的调节
Oncogene. 2016 Apr 14;35(15):1888-98. doi: 10.1038/onc.2015.258. Epub 2015 Jul 6.
3
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.XIAP 限制 Sox2 的自噬降解,是鼻咽癌干细胞的治疗靶点。
Theranostics. 2018 Feb 5;8(6):1494-1510. doi: 10.7150/thno.21717. eCollection 2018.
4
Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.Sox2表达与口腔癌干细胞的致癌性和放化疗抗性有关。
Oral Oncol. 2015 Jan;51(1):31-9. doi: 10.1016/j.oraloncology.2014.10.002. Epub 2014 Oct 24.
5
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis.人 CD59 抑制剂使利妥昔单抗耐药淋巴瘤细胞对补体介导的细胞溶解敏感。
Cancer Res. 2011 Mar 15;71(6):2298-307. doi: 10.1158/0008-5472.CAN-10-3016. Epub 2011 Jan 20.
6
CD59 silencing via retrovirus-mediated RNA interference enhanced complement-mediated cell damage in ovary cancer.通过逆转录病毒介导的RNA干扰使CD59沉默会增强补体介导的卵巢癌细胞损伤。
Cell Mol Immunol. 2009 Feb;6(1):61-6. doi: 10.1038/cmi.2009.8.
7
Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.转录抑制因子 GATA 结合蛋白 1 通过抑制 SRY 盒基因 2 的表达来抑制肿瘤干细胞功能并抑制肿瘤起始。
J Biol Chem. 2018 Nov 30;293(48):18646-18654. doi: 10.1074/jbc.RA118.003983. Epub 2018 Oct 12.
8
Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.SOX2 表达的调控为紫杉醇在乳腺癌干细胞中的有效性划定了一个终点。
Sci Rep. 2017 Aug 23;7(1):9170. doi: 10.1038/s41598-017-08971-2.
9
C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.C-Met 通路促进头颈部鳞状细胞癌干细胞样细胞的自我更新和致瘤性。
Oral Oncol. 2014 Jul;50(7):633-9. doi: 10.1016/j.oraloncology.2014.04.004. Epub 2014 May 15.
10
MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.miR-1181 抑制人胰腺癌细胞中的干细胞样表型并抑制 SOX2 和 STAT3。
Cancer Lett. 2015 Jan 28;356(2 Pt B):962-70. doi: 10.1016/j.canlet.2014.11.007. Epub 2014 Nov 10.

引用本文的文献

1
Exploring the tumor micro-environment in primary and metastatic tumors of different ovarian cancer histotypes.探索不同组织学类型卵巢癌原发肿瘤和转移肿瘤中的肿瘤微环境。
Front Cell Dev Biol. 2024 Jan 24;11:1297219. doi: 10.3389/fcell.2023.1297219. eCollection 2023.
2
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
3
CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity.

本文引用的文献

1
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.通过自分泌抑制WNT实现转移潜伏期和免疫逃逸
Cell. 2016 Mar 24;165(1):45-60. doi: 10.1016/j.cell.2016.02.025.
2
Mouse Cd59b but not Cd59a is upregulated to protect cells from complement attack in response to inflammatory stimulation.小鼠的Cd59b而非Cd59a会在炎症刺激下上调,以保护细胞免受补体攻击。
Genes Immun. 2015 Oct;16(7):437-45. doi: 10.1038/gene.2015.29. Epub 2015 Jul 23.
3
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
CD59 调节的 Ras 区室化调控抗肿瘤 T 细胞免疫。
Cancer Immunol Res. 2022 Dec 2;10(12):1475-1489. doi: 10.1158/2326-6066.CIR-21-1072.
4
Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis.草药NF-κB抑制剂使利妥昔单抗耐药的B淋巴瘤细胞对补体介导的细胞溶解敏感。
Front Oncol. 2021 Dec 8;11:751904. doi: 10.3389/fonc.2021.751904. eCollection 2021.
5
Selecting Hub Genes and Predicting Target Genes of microRNAs in Tuberculosis via the Bioinformatics Analysis.通过生物信息学分析筛选结核病 microRNA 的枢纽基因并预测其靶基因
Genet Res (Camb). 2021 Oct 31;2021:6226291. doi: 10.1155/2021/6226291. eCollection 2021.
6
High-Throughput Proteomic Profiling of Nipple Aspirate Fluid from Breast Cancer Patients Compared with Non-Cancer Controls: A Step Closer to Clinical Feasibility.与非癌症对照相比,乳腺癌患者乳头抽吸液的高通量蛋白质组分析:向临床可行性迈进了一步。
J Clin Med. 2021 May 21;10(11):2243. doi: 10.3390/jcm10112243.
7
Targeting the Complement Pathway in Malignant Glioma Microenvironments.靶向恶性胶质瘤微环境中的补体途径。
Front Cell Dev Biol. 2021 Apr 1;9:657472. doi: 10.3389/fcell.2021.657472. eCollection 2021.
8
Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations.纳米孔测序揭示了不同人类癌症干细胞样细胞群体中线粒体和核糖体基因表达的全球转录组特征。
Cancers (Basel). 2021 Mar 6;13(5):1136. doi: 10.3390/cancers13051136.
9
Immune evasion by cancer stem cells.癌症干细胞的免疫逃逸
Regen Ther. 2021 Mar 11;17:20-33. doi: 10.1016/j.reth.2021.02.006. eCollection 2021 Jun.
10
High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma.LY6基因家族的高mRNA表达与胰腺导管腺癌的总生存结果相关。
Oncotarget. 2021 Feb 2;12(3):145-159. doi: 10.18632/oncotarget.27880.
转化生长因子-β诱导上皮-间质转化对补体依赖性细胞毒性的调节
Oncogene. 2016 Apr 14;35(15):1888-98. doi: 10.1038/onc.2015.258. Epub 2015 Jul 6.
4
The cancer stem cell gamble.癌症干细胞的风险
Science. 2015 Jan 16;347(6219):226-9. doi: 10.1126/science.347.6219.226.
5
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.SOX2 控制鳞状细胞癌的肿瘤起始和癌症干细胞功能。
Nature. 2014 Jul 10;511(7508):246-50. doi: 10.1038/nature13305. Epub 2014 Jun 8.
6
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.双特异性抗体靶向肿瘤相关抗原和中和补体调节因子可提高基于抗体的免疫疗法在小鼠中的疗效。
Leukemia. 2015 Feb;29(2):406-14. doi: 10.1038/leu.2014.185. Epub 2014 Jun 6.
7
Autocrine effects of tumor-derived complement.肿瘤源性补体的自分泌效应
Cell Rep. 2014 Mar 27;6(6):1085-1095. doi: 10.1016/j.celrep.2014.02.014. Epub 2014 Mar 6.
8
NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack.NF-κB 和增强子结合 CREB 蛋白由 CREB 结合蛋白 (CBP)/p300 蛋白构成的支架调节 CD59 蛋白的表达,以保护细胞免受补体攻击。
J Biol Chem. 2014 Jan 31;289(5):2711-24. doi: 10.1074/jbc.M113.525501. Epub 2013 Dec 12.
9
Tumour heterogeneity and cancer cell plasticity.肿瘤异质性和癌细胞可塑性。
Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624.
10
Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.人结肠癌细胞系中CD133+细胞的细胞计量分析确定了一种共同的核心表型和细胞类型特异性镶嵌模式。
Int J Biol Markers. 2013 Sep 27;28(3):267-73. doi: 10.5301/JBM.5000020.